Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci187323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Julia Kuehl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Biozentrum, University of Wurzburg, Wurzburg, Germany. Hauptthemen laut MEDLINE: Fanconi Anemia, Fanconi Anemia Complementation Group Proteins, Ubiquitin-Protein Ligases, Mutation, Missense. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Intramural NIH HHS, Schroeder-Kurth Fund.
Abstract (Originalsprache)
The Fanconi anemia/breast cancer (FA/BRCA) DNA repair network promotes the removal of DNA interstrand crosslinks (ICLs) to counteract their devastating consequences, including oncogenesis. Network signaling is initiated by the FA core complex, which consists of 7 authentic FA proteins and an FA-associated protein, FAAP100, with incompletely characterized roles and unknown disease associations. Upon activation, the FA core complex functions as a multiprotein E3 ubiquitin ligase centered on its catalytic module, the FANCB-FANCL-FAAP100 (BLP100) subcomplex, for FANCD2 and FANCI monoubiquitylation. Here, we identified a homozygous variant in FAAP100 , c.1642A>C, predicting p.(T542P), in a fetus with malformations suggestive of FA. The mutation caused sensitivity to ICL-inducing agents in cells from the affected individual and genetically engineered, FAAP100-inactivated human, avian, zebrafish, and mouse cells. All FAAP100-deficient cell types were rescued by ectopic expression of WT FAAP100, but not FAAP100 T542P . In a confirmatory animal model, customized Faap100 –/– mice exhibited embryonic lethality, microsomia, malformations, and gonadal atrophy resembling mice with established FA subtypes. Mechanistically, FAAP100 T542P impaired ligase activity by preventing BLP100 subcomplex formation, resulting in defective FAAP100 T542P nuclear translocation and chromatin recruitment. FAAP100 dysfunction that disrupted the FA pathway and impaired genomic maintenance, together with FA-consistent human manifestations, recommends FAAP100 as a legitimate FA gene, alias FANCX .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Biozentrum, University of Wurzburg, Wurzburg, Germany.
- Laboratory of Genetics and Genomics, National Institute on Aging, Baltimore, Maryland, USA.
- Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute (NHGRI), NIH, Bethesda, Maryland, USA.
Förderung
- NHLBI NIH HHS
- Intramural NIH HHS
- Schroeder-Kurth Fund
- German Federal Ministry of Education and Research
- National Institute on Aging
- National Heart, Lung, and Blood Institute
Zitieren
APA
Kuehl, J., Xue, Y., Yuan, F., Ramanagoudr-Bhojappa, R., Pickel, S., Kalb, R., Chandrasekharappa, S. C., Wang, W., Zhang, Y., & Schindler, D. (2025). Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex. Journal of Clinical Investigation. https://doi.org/10.1172/jci187323
Vancouver
Kuehl J, Xue Y, Yuan F, Ramanagoudr-Bhojappa R, Pickel S, Kalb R, et al. Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex. Journal of Clinical Investigation. 2025. doi:10.1172/jci187323
BibTeX
@article{Kuehl2025,
author = {Kuehl, Julia and Xue, Yutong and Yuan, Fenghua and Ramanagoudr-Bhojappa, Ramanagouda and Pickel, Simone and Kalb, Reinhard and Chandrasekharappa, Settara C and Wang, Weidong and Zhang, Yanbin and Schindler, Detlev},
title = {Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci187323}
}
EUVIMED